HUP0004341A1 - Heterociklussal szubsztituált új alfa-hidroxi-karbonsavszármazékok, eljárás előááításukra és alkalmazásuk endotelin-receptor antagonistákként - Google Patents
Heterociklussal szubsztituált új alfa-hidroxi-karbonsavszármazékok, eljárás előááításukra és alkalmazásuk endotelin-receptor antagonistákkéntInfo
- Publication number
- HUP0004341A1 HUP0004341A1 HU0004341A HUP0004341A HUP0004341A1 HU P0004341 A1 HUP0004341 A1 HU P0004341A1 HU 0004341 A HU0004341 A HU 0004341A HU P0004341 A HUP0004341 A HU P0004341A HU P0004341 A1 HUP0004341 A1 HU P0004341A1
- Authority
- HU
- Hungary
- Prior art keywords
- group
- general formula
- alkyl
- cycloalkyl
- phenyl
- Prior art date
Links
- 229940118365 Endothelin receptor antagonist Drugs 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 239000002308 endothelin receptor antagonist Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- -1 azido- Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgyát az (I) általános képletű karbonsavszármazékok,ahol A -NR8R9 általános képletű, azido-, -OR10 és -SR10 általánosképletű csoport vagy alkilcsoport; R1 tetrazolil- vagy -C(O)Ráltalános képletű csoport, ahol R -OR5 általános képletű vagy öttagúheteroaromás vagy (2) vagy (3) általános képletű csoport; R5hidrogénatom, alkálifém- vagy alkáliföldfém- vagy ammóniumion, adottesetben szubsztituált alkil-, alkenil-, alkinil-, cikloalkil-, fenil-vagy benzilcsoport; R6 és R7 adott esetben szubsztituált alkil-,alkenil- alkinil-, cikloalkil- vagy fenilcsoport; X és Y oxigén- vagykénatom vagy iminocsoport; R2 és R3 adott esetben szubsztituált vagyegymással összekapcsolt fenil- vagy naftilcsoport vagycikloalkilcsoport; R4 és R11 hidrogén- vagy halogénatom,helyettesített hidroxi- vagy aminocsoport, alkil-, alkenil-, alkinil-vagy alkiltiocsoport; R8 és R9, hidrogénatom, alkil-, cikloalkil-,fenil- vagy naftilcsoport, vagy együtt aliciklusos gyűrűvékapcsolódnak; R10, R12, R13 és R14 különböző csoportokat jelentenek <és fiziológiailag elfogadható sóik, enantiomereik és diasztereomereikképezik. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19750529A DE19750529A1 (de) | 1997-11-14 | 1997-11-14 | Neue heterocyclisch substituierte alpha-Hydroxycarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| PCT/EP1998/007026 WO1999025701A1 (de) | 1997-11-14 | 1998-11-04 | NEUE HETEROCYCLISCH SUBSTITUIERTE α-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004341A1 true HUP0004341A1 (hu) | 2001-10-28 |
| HUP0004341A3 HUP0004341A3 (en) | 2001-12-28 |
Family
ID=7848772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004341A HUP0004341A3 (en) | 1997-11-14 | 1998-11-04 | Novel heterocyclically substituted alpha-hydroxycarboxilic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6358983B1 (hu) |
| EP (1) | EP1037883A1 (hu) |
| JP (1) | JP2001523671A (hu) |
| KR (1) | KR20010032083A (hu) |
| CN (1) | CN1278805A (hu) |
| AR (1) | AR017581A1 (hu) |
| AU (1) | AU752165B2 (hu) |
| BG (1) | BG104400A (hu) |
| BR (1) | BR9814157A (hu) |
| CA (1) | CA2308746A1 (hu) |
| CO (1) | CO4990973A1 (hu) |
| DE (1) | DE19750529A1 (hu) |
| HR (1) | HRP980591A2 (hu) |
| HU (1) | HUP0004341A3 (hu) |
| ID (1) | ID24819A (hu) |
| IL (1) | IL135461A0 (hu) |
| NO (1) | NO20002154L (hu) |
| NZ (1) | NZ504289A (hu) |
| PL (1) | PL340756A1 (hu) |
| SK (1) | SK4932000A3 (hu) |
| TR (1) | TR200001365T2 (hu) |
| WO (1) | WO1999025701A1 (hu) |
| ZA (1) | ZA9810425B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1750862T3 (pl) * | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
| MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
| US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533023B4 (de) | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1997
- 1997-11-14 DE DE19750529A patent/DE19750529A1/de not_active Withdrawn
-
1998
- 1998-11-04 BR BR9814157-0A patent/BR9814157A/pt not_active IP Right Cessation
- 1998-11-04 SK SK493-2000A patent/SK4932000A3/sk unknown
- 1998-11-04 HU HU0004341A patent/HUP0004341A3/hu unknown
- 1998-11-04 ID IDW20000882A patent/ID24819A/id unknown
- 1998-11-04 WO PCT/EP1998/007026 patent/WO1999025701A1/de not_active Application Discontinuation
- 1998-11-04 IL IL13546198A patent/IL135461A0/xx unknown
- 1998-11-04 PL PL98340756A patent/PL340756A1/xx not_active Application Discontinuation
- 1998-11-04 AU AU14878/99A patent/AU752165B2/en not_active Ceased
- 1998-11-04 NZ NZ504289A patent/NZ504289A/en unknown
- 1998-11-04 CA CA002308746A patent/CA2308746A1/en not_active Abandoned
- 1998-11-04 JP JP2000521084A patent/JP2001523671A/ja active Pending
- 1998-11-04 KR KR1020007005207A patent/KR20010032083A/ko not_active Application Discontinuation
- 1998-11-04 CN CN98811085A patent/CN1278805A/zh active Pending
- 1998-11-04 EP EP98958900A patent/EP1037883A1/de not_active Withdrawn
- 1998-11-04 TR TR2000/01365T patent/TR200001365T2/xx unknown
- 1998-11-04 US US09/530,382 patent/US6358983B1/en not_active Expired - Fee Related
- 1998-11-09 AR ARP980105651A patent/AR017581A1/es not_active Application Discontinuation
- 1998-11-13 HR HR19750529.5A patent/HRP980591A2/hr not_active Application Discontinuation
- 1998-11-13 ZA ZA9810425A patent/ZA9810425B/xx unknown
- 1998-11-13 CO CO98067231A patent/CO4990973A1/es unknown
-
2000
- 2000-04-27 NO NO20002154A patent/NO20002154L/no not_active Application Discontinuation
- 2000-05-04 BG BG104400A patent/BG104400A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG104400A (en) | 2001-01-31 |
| WO1999025701A1 (de) | 1999-05-27 |
| JP2001523671A (ja) | 2001-11-27 |
| AR017581A1 (es) | 2001-09-12 |
| HUP0004341A3 (en) | 2001-12-28 |
| SK4932000A3 (en) | 2001-02-12 |
| NZ504289A (en) | 2002-03-01 |
| CA2308746A1 (en) | 1999-05-27 |
| AU752165B2 (en) | 2002-09-05 |
| AU1487899A (en) | 1999-06-07 |
| NO20002154L (no) | 2000-05-12 |
| KR20010032083A (ko) | 2001-04-16 |
| TR200001365T2 (tr) | 2000-09-21 |
| BR9814157A (pt) | 2000-10-03 |
| IL135461A0 (en) | 2001-05-20 |
| EP1037883A1 (de) | 2000-09-27 |
| US6358983B1 (en) | 2002-03-19 |
| PL340756A1 (en) | 2001-02-26 |
| ID24819A (id) | 2000-08-24 |
| HRP980591A2 (en) | 1999-08-31 |
| NO20002154D0 (no) | 2000-04-27 |
| CN1278805A (zh) | 2001-01-03 |
| CO4990973A1 (es) | 2000-12-26 |
| ZA9810425B (en) | 2000-05-15 |
| DE19750529A1 (de) | 1999-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0590919T3 (da) | Terapeutiske midler mod Parkinsons sygdom | |
| ATE159950T1 (de) | N-alkyl-2-substituierte atp-analoge | |
| HUP0300641A2 (hu) | Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények | |
| HUP0401293A2 (hu) | Új dihidropteridinonok, eljárás előállításukra és alkalmazásuk gyógyszerként | |
| ES8802493A1 (es) | Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos. | |
| ZA9811576B (en) | Anilide derivative, production and use thereof. | |
| HUP9901820A2 (hu) | 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra | |
| PT1159279E (pt) | 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais | |
| MY104627A (en) | A 1-pyridylimidazole derivative and its production and use. | |
| TR200201638T2 (tr) | Yeni imidazo[1,3,5]triazinonlar ve kullanımları | |
| CY1106672T1 (el) | Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα | |
| SE0101579D0 (sv) | New compounds | |
| HUP0104058A2 (hu) | N-diszubsztituált piperazin vagy 1,4 diszubsztituált piperidin heterociklusos származékai és ezeket tartalmazó gyógyászati készítmények | |
| ATE186301T1 (de) | An den positionen 2 und 9 substituierte 4h-pyrido-(1,2-a)pyrimidin-4-one | |
| HUP0101751A2 (hu) | Fungicid hatású 6-(4-alkoxi-2-halogén-fenil)-triazolo-pirimidin-származékok, intermedierjeik, előállításuk és alkalmazásuk | |
| BG106080A (en) | Cyclothiocarbamate derivatives as progesterone receptor modulators | |
| HUP0004341A1 (hu) | Heterociklussal szubsztituált új alfa-hidroxi-karbonsavszármazékok, eljárás előááításukra és alkalmazásuk endotelin-receptor antagonistákként | |
| BG105373A (en) | 2-phenylpyran-4-one derivatives | |
| DE60001807D1 (de) | VERFAHREN ZU HERSTELLUNG VON o-FLUORIERTEN TETRAHYDROTHIOPYRAN CARBAMATEN | |
| HUP0201321A2 (hu) | Új béta-amido- és béta-szulfonamido-karbonsavszármazékok, előállításuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0202646A2 (hu) | 5,6-Szubsztituált pirimidin-gyűrűt tartalmazó új karbonsavszármazékok, előállításuk, alkalmazásuk endotelin receptor antagonista gyógyszerkészítmények előállítására és a vegyületeket tartalmazó gyógyszerkészítmények | |
| GEP19960472B (en) | Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts | |
| TH54292B (th) | กรรมวิธีสำหรับการเตรียม n-แอริล-แอนธรานิลิคแอซิด และอนุพันธ์ของสารเหล่านั้น | |
| MX9702028A (es) | Antagonistas de bradiquinina heterociclicos, sustituidos con fluoroalquilo y fluoroalcoxi, procedimientos para su preparacion y su utilizacion. |